Abstract
Chronic kidney disease (CKD) is characterized by muscle atrophy, fatigue intolerance and other indicators of muscle dysfunction, collectively termed uremic myopathy, with devastating consequences in overall health status and mortality rates. Although many factors such as metabolic acidosis, substrate availability and neuropathy have been implicated, the mechanisms underlying uremic myopathy have not yet been fully understood. However, there is clear evidence that muscle specific factors such as fiber atrophy, fiber type alterations and mitochondrial abnormalities are presented in muscle biopsies of CKD patients and can negatively affect muscle contraction. Counteracting measures such as exercise and nutritional interventions have been shown to improve muscle performance, health indices and overall quality of life of CKD patients. However, little is known about their effects on factors affecting muscle contraction at the muscle biopsy level and therefore on the mechanisms underlying uremic myopathy. The current systematic review aims to summarize the effects of recent interventional studies on muscle contraction determinants based on muscle biopsies of human patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GM was supported in the context of the project "Reinforcement of Postdoctoral Researchers - 2nd Cycle" (MIS-5033021), co-financed by Greece and the European Union (European Social Fund - ESF) through the Operational Programme "Human Resources Development, Education and Lifelong Learning", implemented by the State Scholarships Foundation (IKY).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
